Amgen lines up new AI biotech partner in PostEranews2023-11-16T14:00:46+00:00November 16th, 2023|Endpoints News|
Q32 Bio to take Homology Medicines’ Nasdaq spot to fund PhII trials in autoimmune, inflammatory conditionsnews2023-11-16T13:44:56+00:00November 16th, 2023|Endpoints News|
Rakuten Medical targets year-end close for $100M+ Series E to fund photoimmunotherapy pipeline: #Jefferies23news2023-11-16T12:13:32+00:00November 16th, 2023|Endpoints News|
Bristol Myers Squibb scores FDA approval for lung cancer drug from Turning Point buyoutnews2023-11-16T12:05:38+00:00November 16th, 2023|Endpoints News|
UK approves Vertex, CRISPR therapy for sickle cell disease, beta-thalassemia in world firstnews2023-11-16T11:15:22+00:00November 16th, 2023|Endpoints News|
Alnylam, Bicycle, Intellia, Nouscom, Rakuten Medical execs forecast 2024: #Jefferies23news2023-11-16T11:08:34+00:00November 16th, 2023|Endpoints News|
Astellas to acquire prostate cancer drugmaker Propella Therapeutics for $175Mnews2023-11-16T10:01:38+00:00November 16th, 2023|Endpoints News|
Investors OrbiMed and Foresite say they’re looking at taking Kinnate private, following pipeline and staff cutsnews2023-11-15T23:04:51+00:00November 15th, 2023|Endpoints News|
Novo Nordisk launches head-to-head trial with Eli Lilly as weight loss rivalry heats upnews2023-11-15T20:03:48+00:00November 15th, 2023|Endpoints News|
Pharmas and physicians value medical affairs and MSLs, but have different content priorities, survey saysnews2023-11-15T20:02:19+00:00November 15th, 2023|Endpoints News|
